Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Stimulants in breastfeeding
Stimulants in depression
Stimulants in hepatic impairment
Stopping Antipsychotic prophylaxis General principles of prescribing hyperbolic reduction schedule Olanzapine long-acting injection pattern of tapering reduction of olanzapine Stopping antipsychotics tapering in practice when to attempt discontinuation withdrawal effects
Stopping lithium and other mood stabilisers Stopping lithium and mood stabilisers tapering lithium valproate
Stopping medication abrupt cessation by non-compliant patients antidepressants antipsychotics benzodiazepines lithium long-acting antipsychotics reducing impacts of non-adherence
Stroke antipsychotic risks dyslipidaemia post stroke depression
Stuttering, and antipsychotics
Sublingual administration antipsychotics buprenorphine
Substance misuse and dependence
Sudden cardiac death
Sudden cardiac death, antidepressants
Suggested guidelines for managing cardiovascular risk prior to and during treatment with acetylcholinesterase inhibitors (AChE-Is) in Alzheimer's disease.
Suggested monitoring for myocarditis
Suggested monitoring for people receiving antipsychotic medication
Suggested options for augmenting clozapine
Suggested titration regimens for initiation of clozapine in the community
Suicidality
Suicide risk in children and adolescents
Sulpiride Antipsychotics - minimum effective doses clozapine augmentation clozapine-induced hypersalivation treatment Equivalent doses Quick reference for licensed maximum doses Relative adverse effects - a rough guide typical or atypical classification use in patients with hepatic impairment
Summary of alternatives to clozapine in refractory schizophrenia
Summary of antidepressant effects on CYP enzymes
Summary of antipsychotic/oestrogen interactions
Summary of biochemical changes associated with psychotropics
Summary of British Association for Psychopharmacology recommendations
Summary of drugs of misuse
Summary of haematological changes associated with psychotropics
Summary of maintenance in bipolar disorder
Summary of pharmacotherapy for depression in children and adolescents
Summary of psychiatric adverse drug reactions (ADRs) with antiretroviral drugs